Skip to main content

Together we are beating cancer

Donate now

Blood test

Showing 11 out of 35 results
Cancer Research UK logo

A genetic pattern could predict how aggressive prostate cancer is before treatment, and whether the disease will come back in men who have already been treated, according to research published in the Lancet Oncology*. A genetic pattern could predict how aggressive prostate cancer is before treatment, and whether the disease will come back in men who have already been treated, according to research published in the Lancet Oncology*.

by Cancer Research UK | News | 9 February 2011

9 February 2011

Cancer Research UK logo

Scientists have pinpointed key changes to the telomeres in the cells of leukaemia patients which could play a crucial role in the earliest stages of the disease, according to research published online in the journal Blood. Scientists have pinpointed key changes to the telomeres in the cells of leukaemia patients which could play a crucial role in the earliest stages of the disease, according to research published online in the journal Blood.

by Cancer Research UK | News | 10 June 2010

10 June 2010

Cancer Research UK logo

CANCER RESEARCH UK scientists have shown that screening for prostate cancer using prostate specific antigen (PSA) would lead to a substantial number of tumours diagnosed at an earlier and more treatable stage. However, there would be likely cases of overdiagnosed prostate cancer according to a study published in the British Journal of Cancer today. CANCER RESEARCH UK scientists have shown that screening for prostate cancer using prostate specific antigen (PSA) would lead to a substantial number of tumours diagnosed at an earlier and more treatable stage. However, there would be likely cases of overdiagnosed prostate cancer according to a study published in the British Journal of Cancer today.

by Cancer Research UK | News | 1 April 2009

1 April 2009

Cancer Research UK logo

CANCER RESEARCH UK-funded scientists have identified a new molecular marker in blood which could indicate how patients with a type of lung cancer will respond to treatment, according to research published in Clinical Cancer Research*. CANCER RESEARCH UK-funded scientists have identified a new molecular marker in blood which could indicate how patients with a type of lung cancer will respond to treatment, according to research published in Clinical Cancer Research*.

by Cancer Research UK | News | 1 January 2009

1 January 2009

Cancer Research UK logo

Male relatives of prostate cancer patients need more information in order to help them understand the possible familial risk of the disease, and to decide whether or not to have a PSA test, according to research published in the British Journal of Cancer today (21 February 2006). Male relatives of prostate cancer patients need more information in order to help them understand the possible familial risk of the disease, and to decide whether or not to have a PSA test, according to research published in the British Journal of Cancer today (21 February 2006).

by Cancer Research UK | News | 21 February 2006

21 February 2006

Cancer Research UK logo

Scientists at Birmingham University are using cutting edge technologies to move closer to a blood test that will improve early diagnosis of liver cancer in high risk groups, according to research published in the British Journal of Cancer today (Tuesday 24 January 2006). Scientists at Birmingham University are using cutting edge technologies to move closer to a blood test that will improve early diagnosis of liver cancer in high risk groups, according to research published in the British Journal of Cancer today (Tuesday 24 January 2006).

by Cancer Research UK | News | 24 January 2006

24 January 2006

Cancer Research UK logo

Cancer Research UK scientists hope to use a simple blood test to discover which ovarian cancer patients become resistant to chemotherapy - says a leading researcher at the charity's conference in Harrogate, Yorkshire. Cancer Research UK scientists hope to use a simple blood test to discover which ovarian cancer patients become resistant to chemotherapy - says a leading researcher at the charity's conference in Harrogate, Yorkshire.

by Cancer Research UK | News | 17 May 2004

17 May 2004

Cancer Research UK logo

A molecule involved in tumour development is found in high concentrations in the blood of lung cancer patients, and could act as an early indicator of the disease, according to research published in the British Journal of Cancer1. A molecule involved in tumour development is found in high concentrations in the blood of lung cancer patients, and could act as an early indicator of the disease, according to research published in the British Journal of Cancer1.

by Cancer Research UK | News | 12 March 2002

12 March 2002